Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
975878
Reference Type
Journal Article
Subtype
Abstract
Title
Role of the GTP Cyclohydrolase I regulatory protein in modulating human endothelial cell nitric oxide production
Author(s)
Li, L; Chen, W; Harrison, DG
Year
2008
Is Peer Reviewed?
Yes
Journal
Free Radical Biology and Medicine
ISSN:
0891-5849
EISSN:
1873-4596
Volume
45
Issue
Suppl.
Page Numbers
S114-S115
Language
English
Web of Science Id
WOS:000260867900326
URL
http://www.sciencedirect.com/science/article/pii/S089158490800628X
Exit
Relationship(s)
is part of a larger document
3452652
SFRBM's 15th Annual Meeting: Program and Abstracts
Abstract
GTP cyclohydrolase-I (GTPCHI) is the rate-limiting enzyme involved in the biosynthesis of tetrahydrobiopterin (BH4), an essential cofactor for nitric oxide synthase. We have previously shown that laminar shear stress increases BH4 production in human aortic endothelial cells (HAECs) by enhancing GTPCHI activity via Casein Kinase 2 (CK2)-dependent phosphorylation on serine 81. CK2 is usually constitutively active and phosphorylates an array of substrates when their phosphorylation sites are exposed upon release from binding partners. We therefore sought to determine if GTPCHI binding proteins might modulate its activity. One such protein is Activator of Heat Shock 90 kDa Protein (Aha1) which was found to interact with GTPCHI in a yeast two-hybrid system. We found that HAECs express Aha1 by western blotting; however, downregulation of Aha1 by siRNA transfection did not affect HAEC BH4 levels. in non-endothelial cells, another binding partner of GTPCHI is the GTP cyclohydrolase I feedback regulatory protein (GFRP). We found that GFRP is abundantly expressed in HAECs by real time PCR. Transfection with siRNA against GFRP caused a striking increase of BH4 levels in HAECs (from near undetectable values to 46.4 ± 5.0 pmol/mg protein, p<0.0001) and non-silencing siRNA had no effect on BH4 levels. GFRP siRNA treatment of HAECs also increased phosphorylation of GTPCHI on serine 81 and augmented its enzymatic activity (from near undetectable values to 1.65 ± 0.12 µUnits/mg protein, p<0.0001) without changing its protein level. Exposure of HAECs transfected with GFRP siRNA to laminar shear stress did not further increase BH4 levels (48.7 ± 2.9 pmol/mg protein, p=0.71). Finally, we found that HAEC NO production is dramatically increased following downregulation of GFRP compared to non-silencing siRNA (3891.5 ± 969.0 pmol/mg protein vs. 683.5 ± 141.4 pmol/mg protein, p=0.02). Thus, GFRP plays a major role in regulation of human endothelial cell GTPCHI enzyme activity, BH4 levels and NO production. While Aha1 has been reported to bind GTPCHI, our data indicate that it has little role in modulating its activity in endothelial cells.
Conference Name
Society for Free Radical Biology and Medicine 15th Annual Meeting
Conference Location
Indianapolis, IN
Conference Dates
November 19-23, 2008
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity